 Avrobio NASDAQ:AVRO and Editas Medicine NASDAQ:EDIT are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability. Volatility Risk Avrobio has a beta of 1.74, suggesting that its stock price is 74 ... 